Acute Lymphocytic Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT - 2022
Completed
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Busulfan (BU)
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
2022-03-30
Mar 30, 2022
M
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
Recruiting
  • Acute Lymphocytic Leukemia
  • Lymphoma
  • Biological/Genetically Modified T cells
  • Cyclophosphamide-based chemotherapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-04-07
Apr 7, 2022
N
Reduced Intensity Conditioning Transplant Using Haploidentical Donors - 2020
Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
2022-04-04
Apr 4, 2022
I
A Triple-targeted Cell Preparation Targeting CD19/CD20/CD22 in Patients With Relapsed/Refractory B-cell Acute Lymphocytic Leukemia
Not yet recruiting
  • Acute Lymphocytic Leukemia
  • LCAR-AIO Cells
  • Beijing, Beijing, China
  • +1 more
2022-03-14
Mar 14, 2022
W
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Recruiting
  • Acute Myelogenous Leukemia
  • +4 more
  • Stem cell transplantation
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-10
Mar 10, 2022
N
IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT - 2021
Terminated
  • Acute Myeloid Leukemia
  • +3 more
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
2022-02-22
Feb 22, 2022
W
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
Recruiting
  • Non-hodgkin Lymphoma
  • Acute Lymphocytic Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-01
Mar 1, 2022
U
Pilot Imaging Study of Leukemia
Not yet recruiting
  • Acute Lymphocytic Leukemia
  • +3 more
  • Washington, District of Columbia
  • +2 more
2022-02-21
Feb 21, 2022
N
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Leukemia (AML, ALL), MDS, MDS/MPN, and MF
Recruiting
  • Non Hodgkin Lymphoma
  • +8 more
  • Chicago, Illinois
  • +1 more
2022-02-14
Feb 14, 2022
U
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
Recruiting
  • Multiple Myeloma
  • +11 more
  • Pre-biotic foods/drinks
  • Charlottesville, Virginia
    University of Virginia
2022-02-14
Feb 14, 2022
B
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
Active, not recruiting
  • B Cell Lymphoma
  • +2 more
  • Houston, Texas
  • +1 more
2022-02-10
Feb 10, 2022
I
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias or Solid Tumors
Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Ghent, Belgium
  • +23 more
2022-02-07
Feb 7, 2022
B
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
2022-01-25
Jan 25, 2022
B
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Recruiting
  • Non-Hodgkin Lymphoma
  • +2 more
  • CD19 CAR T Cells
  • +2 more
  • Houston, Texas
  • +1 more
2022-01-11
Jan 11, 2022
N
A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies
Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Fludarabine + Total Marrow Irradiation
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
2022-01-07
Jan 7, 2022
T
Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia - 2021
Completed
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Fairway, Kansas
    University of Kansas Cancer Center - Clinical Research Center
2022-01-12
Jan 12, 2022
O
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies
Not yet recruiting
  • Acute Leukemia
  • +6 more
  • (no location specified)
2021-12-08
Dec 8, 2021
V
Allogeneic Stem Cell Transplantationin Relapsed Hematological Malignancy: Early GVHD Prophylaxis
Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
2021-12-21
Dec 21, 2021
I
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • +3 more
  • Gilbert, Arizona
  • +14 more
2021-12-03
Dec 3, 2021
M
Double Cord Versus Haploidentical (BMT CTN 1101) - 2020
Completed
Has Results
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
2021-11-02
Nov 2, 2021
W
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Recruiting
  • Acute Myelogenous Leukemia
  • +9 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Health
    2021-11-23
    Nov 23, 2021
    M
    Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies
    Active, not recruiting
    • B-Lymphoid Malignancies
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2021-11-18
    Nov 18, 2021
    N
    Human Placental-Derived Stem Cell Transplantation
    Active, not recruiting
    • Mucopolysaccharidosis I
    • +15 more
    • Human Placental Derived Stem Cell
    • Denver, Colorado
    • +2 more
    2021-10-29
    Oct 29, 2021
    M
    Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) - 2014
    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    2021-10-13
    Oct 13, 2021
    A
    Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies - 2021
    Completed
    • Relapsed or Refractory Haematological Malignancies Including
    • +10 more
    • Aachen, Germany
    • +11 more
    2021-10-21
    Oct 21, 2021